Delayed EU pharmaceutical package launch sees industry concerned for its survival
This article was originally published in RAJ Devices
Executive Summary
EU Enterprise and Industry Commissioner Günter Verheugen’s announcement yesterday that the European Commission’s “pharmaceutical package” is set to be delayed has sent a ripple of concern through the pharmaceutical industry. The European Federation of Pharmaceutical Industries and Associations (EFPIA) has since called on the Commission to act quickly to progress the package in the interests of patient safety. “This package has been a long time in gestation; it is disappointing to see it further delayed at this late stage,” said EFPIA Director General Brian Ager.